HB 127Session 2026rs
Pharmaceuticals; prohibiting the Board of Pharmacy from disciplining pharmacists who recommend off-label use of a drug; allowing over-the-counter sale of Ivermectin and Hydroxychloroquine.
Progress
- Introduced
- In committee
- Passed one chamber Not yet
- Passed legislature Not yet
- Sent to governor Not yet
- Became law Not yet
Legislative history
-
House
Read for the first time and referred to the House Committee on Health
-
House
Pending Committee Action in House of Origin (Health)
-
House
Filed